10% Owner of Kaleido Biosciences, Inc. (NASDAQ:KLDO), Flagship Ventures Fund Iv Gene, buys 215,000 shares worth $2,472,500
According to Kaleido Biosciences, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 10 05:30 PM, company 10% Owner, Flagship Ventures Fund Iv Gene disclosed buying 215,000 shares at a cost of $11.50. At the time of this transaction (Feb 08), this trade was worth $2,472,500 in total. As of Feb 08, Flagship Ventures Fund Iv Gene now owns 2,982,639 shares in total worth about $32,838,855.39.
For the last few recent trades made by Kaleido Biosciences, Inc. (NASDAQ:KLDO) 10% Owner, Flagship Ventures Fund Iv Gene, we have the following information:
- SEC Form 4 filing: Jun 04: Bought 2,000,000 shares at the rate of $7.50 per share. Total worth of this trade was $15,000,000. Total number of shares owned as of Jun 04 were 2,910,972
Posted by
George Daniels
on Wednesday February 10 2021, 10:17 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
